Showing 281-290 of 327 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Synthetic Hydrogels for Islet Vascularization and Engraftment | Georgia Tech Research Corporation | Andres Garcia | Cures | 01-July-2022 to 30-June-2026 | $563.235,05 |
| Investigation of novel local immunomodulating strategies to enhance islet transplantation for T1D | The Methodist Hospital Research Institute | Alessandro Grattoni | Cures | 01-July-2022 to 30-June-2026 | $962.995,99 |
| Changing the T1DE: A randomized controlled trial comparing ACT to supportive diabetes counseling | Duke University | Rhonda Merwin | Improving Lives | 01-July-2022 to 30-June-2027 | $2.534.224,22 |
| In vivo analysis of human islet graft infiltration and its immunomodulation by antigen-specific therapy | Trustees of Columbia University in the City of New York | Remi Creusot | Cures | 01-August-2022 to 31-July-2025 | $699.997,82 |
| Innovating Methods for AssessinG INsulin Action in Type ONe diabetes (IMAGINATiON) | Regents of the University of Colorado | Kristen Nadeau | Improving Lives | 01-December-2021 to 30-November-2025 | $445.816,29 |
| EFFICACY AND SAFETY OF ONCE WEEKLY SEMAGLUTIDE IN ADULTS WITH OBESITY AND INADEQUATELY CONTROLLED TYPE 1 DIABETES USING HYBRID CLOSED-LOOP SYSTEM | Regents of the University of Colorado | Janet Snell-Bergeon | Improving Lives | 01-November-2022 to 31-October-2026 | $2.282.771,83 |
| Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes | Regents of the University of Colorado | Jessica Kendrick | Improving Lives | 01-October-2022 to 30-September-2026 | $899.235,00 |
| Understanding the role of scaffold microarchitecture on survival and function of stem cell-derived beta cells | Brown University | Tejal Desai | Cures | 01-October-2022 to 30-September-2025 | $474.761,58 |
| Avera eCare School Health T1D Demonstration Project | Avera McKennan | Christine Hockett | Improving Lives | 01-November-2021 to 31-July-2025 | $4.000.979,73 |
| Ultrafast Insulin-Pramlintide Co-formulations | Stanford University | Eric Appel | Improving Lives | 01-September-2022 to 31-August-2025 | $795.000,00 |